Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Free Report) was the target of a significant increase in short interest during the month of September. As of September 15th, there was short interest totalling 1,430,000 shares, an increase of 25.4% from the August 31st total of 1,140,000 shares. Based on an average trading volume of 336,400 shares, […]
Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.